This announcement is a separate document:
Mesoblast Ltd: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.